Credit Suisse raised the firm’s price target on Molina Healthcare to $350 from $347 and keeps an Outperform rating on the shares. Management continues to take a conservative stance relative to its financial outlook, with no change towards the remainder of the year after Q1 outperformed expectations, the analyst tells investors in a research note.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on MOH:
- Molina Healthcare boosts FY23 adj. EPS view to at least $20.25, consensus $19.70
- Molina Healthcare reports Q1 adjusted EPS $5.81, consensus $5.12
- Molina Healthcare initiated with an Overweight at Cantor Fitzgerald
- Molina Healthcare price target lowered to $282 from $307 at Wells Fargo
- Centene price target lowered to $71 from $79 at Wells Fargo
